drugset

drugset / Trial / NCT00595270

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

NCT00595270 ↗

Phase 3 Completed 349 enrolled Valneva Austria GmbH

NaSingle-groupOpen-labelPrevention

Summary

The study investigates the long term persistence the Japanese encephalitis vaccine IC51 and the need of a booster dose

Timeline

Start: 2005-10
Primary completion: 2007-09
Completion: 2009-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IC51	Vaccine	6 ug	—

Indications